Bespoke consultancy service
Our consultancy team is experienced in cannabinoid chemistry (including CBD and other plant derived cannabinoids), manufacturing, regulatory and related analytical methodology.
ACI technical consultancy includes
Introduction to novel foods dossier requirements
Customer checklist reviewed and signed off by ACI
Gap analysis based on checklist results
Definition of project timeline and approval
Full review of each section on completion
Advice on identifying partners for stability testing and advice on identifying partners for product testing
Formulation-specific risk assessment guidance
Stability data protocols
Supply chain visibility HACCP, GACP and other critical control points
Guidance on data generation, such as toxicological data or ADME studies
Overall risk assessment & risk mitigation plan guidance
In February 2020 the UK Food Standards Agency set out a new deadline for the CBD industry to apply for European Union safety evaluations known as a “novel foods authorisation” and also provided consumption guidelines to consumers. They set a deadline for all products on the market prior to 13 February 2020 to submit a novel foods application to them by 31 March 2021.
Products that were not on the market prior to 13 February 2021 require a full novel foods authorisation from the FSA to be sold in the UK.
To assist our members in producing the necessary scientific dossiers for their novel foods applications ACI launched a CBD safety study to generate the required data. The novel foods dossiers linked to this study were submitted on 16 February 2021.
The data generated through this study can help your company enter the lucrative UK and European markets.